APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
NXN |
Q6DKJ4
|
nucleoredoxin
|
|
1.00 |
0.584 |
0.577 |
CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
MYRF |
Q9Y2G1
|
myelin regulatory factor
|
|
1.00 |
0.584 |
0.731 |
TMEM258 |
P61165
|
transmembrane protein 258
|
|
1.9E-03 |
0.644 |
0.654 |
CDH3 |
P22223
|
cadherin 3
|
|
2.8E-10 |
0.560 |
0.615 |
TCF7L2 |
Q9NQB0
|
transcription factor 7 like 2
|
|
1.00 |
0.485 |
0.846 |
ZMIZ1 |
Q9ULJ6
|
zinc finger MIZ-type containing 1
|
|
1.00 |
0.588 |
0.615 |
PNKD |
Q8N490
|
PNKD metallo-beta-lactamase domain containing
|
|
4.1E-08 |
0.615 |
0.615 |
COL4A2 |
P08572
|
collagen type IV alpha 2 chain
|
|
3.6E-15 |
0.563 |
0.654 |
LRP1 |
Q07954
|
LDL receptor related protein 1
|
|
1.00 |
0.482 |
0.769 |
CHD1 |
O14646
|
chromodomain helicase DNA binding protein 1
|
|
1.00 |
0.628 |
0.692 |
RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
UTP23 |
Q9BRU9
|
UTP23 small subunit processome component
|
|
8.6E-02 |
0.711 |
0.385 |
PIGU |
Q9H490
|
phosphatidylinositol glycan anchor biosynthesis class U
|
|
1.9E-05 |
0.670 |
0.462 |
GREM1 |
O60565
|
gremlin 1, DAN family BMP antagonist
|
|
0.47 |
0.508 |
0.808 |
HHIP |
Q96QV1
|
hedgehog interacting protein
|
|
0.95 |
0.550 |
0.654 |
C5orf66 |
Q9H5L9
|
chromosome 5 open reading frame 66
|
|
5.3E-04 |
0.760 |
0.154 |
CASC8 |
|
cancer susceptibility 8
|
|
|
0.670 |
0.462 |
TOX2 |
Q96NM4
|
TOX high mobility group box family member 2
|
|
3.2E-02 |
0.736 |
0.154 |
ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
LINC00511 |
|
long intergenic non-protein coding RNA 511
|
|
|
0.638 |
0.423 |
POU5F1B |
Q06416
|
POU class 5 homeobox 1B
|
|
2.9E-04 |
0.670 |
0.346 |